Arlington Trust’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-92
Closed -$3.12K – 989
2026
Q2
$3.12K Hold
92
– – ﹤0.01% 611
2026
Q1
$2.77K Buy
+92
New +$2.96K ﹤0.01% 613
2024
Q1
– Sell
-214
Closed -$2.23K – 850
2023
Q4
$2.23K Hold
214
– – ﹤0.01% 610

Other funds holding TEVA

Arlington Trust's TEVA Position: Q3 2026 in Review

Arlington Trust sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2026, closing a stake of 92 shares — an estimated $3.12K sold.

Arlington Trust first reported a position in TEVA in Q4 2023 and held it in 3 quarters. The position peaked at $3.12K in Q2 2026. 600 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Arlington Trust reported no remaining Teva Pharmaceutical Industries position as of Q3 2026 after selling out during the quarter.
  • Arlington Trust sold 92 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $3.12K.
  • Arlington Trust first reported a position in Teva Pharmaceutical Industries in Q4 2023 and held it in 3 quarters.
  • Arlington Trust's Teva Pharmaceutical Industries position peaked at $3.12K in Q2 2026.
  • 600 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.